NCT00290745View on ClinicalTrials.gov

Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

February 19, 2002

Primary Completion Date

July 31, 2009

Study Completion Date

June 30, 2011

Conditions
Breast Cancer
Interventions
DRUG

letrozole

DRUG

tamoxifen citrate

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University of California, San Francisco

OTHER

NCT00290745 - Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ | Biotech Hunter | Biotech Hunter